Login to Your Account

With Increasing Product Sales, Genzyme Beats Q3 Estimates

By Aaron Lorenzo

Thursday, October 16, 2003
Genzyme Corp. beat consensus earnings estimates for the third quarter, without taking into account the company's purchase of SangStat Medical Corp., and raised its fourth-quarter and year-end financial outlook. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription